Intensity Therapeutics Announces Positive Early Data from INVINCIBLE-4 Study of INT230-6

Article summary

Intensity Therapeutics reported that 71% of patients in the first cohort of its INVINCIBLE-4 study achieved a pathological complete response following treatment with INT230-6.